The Future of Child and Adolescent Clinical Psychopharmacology: A Systematic Review of Phase 2, 3, or 4 Randomized Controlled Trials of Pharmacologic Agents Without Regulatory Approval or for Unapproved Indications
Samuele Cortese,Katherine McGinn,Mikkel Højlund,Alan Apter,Celso Arango,Immaculada Baeza,Tobias Banaschewski,Jan Buitelaar,Josefina Castro-Fornieles,David Coghill,David Cohen,Edna Grünblatt,Anthony James,Pia Jeppesen,Péter Nagy,Anne Katrine Pagsberg,Mara Parellada,Diane Purper-Ouakil,Veit Roessner,Paramala Santosh,Emily Simonoff,Dejan Stevanovic,Argyris Stringaris,Benedetto Vitiello,Susanne Walitza,Abraham Weizman,Tamar Wohlfarth,Ian C K Wong,Gil Zalsman,Alessandro Zuddas,Carmen Moreno,Marco Solmi,Pieter J. Hoekstra,Antonio M. Persico,Christoph U. Correll
DOI: https://doi.org/10.1016/j.neubiorev.2023.105149
2023-03-31
Abstract:The pace of development and implementation of novel medications in child and adolescent psychiatry has remained slow. We systematically searched https://clinicaltrials.gov/ and https://www.clinicaltrialsregister.eu/ (from 01/01/2010 to 08/23/2022) for phase 2 or 3 randomized controlled trials (RCTs) of medications without regulatory approval in the US, Europe or Asia. We also included RCTs of dietary interventions/probiotics. Additionally, we searched phase 4 RCTs of agents targeting unlicensed indications for children/adolescents with mental health disorders. We retrieved 234 ongoing or completed RCTs, including 26 (11%) with positive findings on ≥1 primary outcome, 43 (19%) with negative/unavailable results on every primary outcome, and 165 (70%) without publicly available statistical results. The only two compounds with evidence of significant effects that were replicated in ≥1 additional RCT without any negative RCTs were dasotraline for attention-deficit/hyperactivity disorder, and carbetocin for hyperphagia in Prader-Willi syndrome. Among other strategies, targeting specific symptom dimensions in samples stratified based on clinical characteristics or established biomarkers may increase chances of success in future development programmes.
behavioral sciences,neurosciences